Drugs / Trinity
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00851162 | Mar 2009 → Mar 2010 | bone neoplasm | Emory University | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trinity | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00851162 ↗ |
| Modality | Cell therapy | “Trinity multipotent stem cells” NCT00851162 ↗ |